Diosgenin induces genotoxic and mutagenic effects on HepG2 cells
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 120, 98-103
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (477389/2009-0)
This publication has 39 references indexed in Scilit:
- Bioassay-guided evaluation of Dioscorea villosa – an acute and subchronic toxicity, antinociceptive and anti-inflammatory approachBMC Complementary and Alternative Medicine, 2013
- Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathwaysJournal of Applied Toxicology, 2012
- Application of the comet assay method in clinical studiesWiener klinische Wochenschrift, 2011
- Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosisChemico-Biological Interactions, 2010
- Design, synthesis and biological evaluation of 2H-benzo[b][1,4] oxazine derivatives as hypoxia targeted compounds for cancer therapeuticsBioorganic & Medicinal Chemistry Letters, 2009
- Novel effects of diosgenin on skin agingSteroids, 2009
- The comet assay: topical issuesMutagenesis, 2008
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Diosgenin Induces Hypoxia-Inducible Factor-1 Activation and Angiogenesis through Estrogen Receptor-Related Phosphatidylinositol 3-kinase/Akt and p38 Mitogen-Activated Protein Kinase Pathways in OsteoblastsMolecular Pharmacology, 2005
- Glycoalkaloids and Metabolites Inhibit the Growth of Human Colon (HT29) and Liver (HepG2) Cancer CellsJournal of Agricultural and Food Chemistry, 2004